QuadMed Adds Accomplished Health Care Executives to Leadership Team
SUSSEX, Wis., June 23, 2021 /PRNewswire/ -- QuadMed, LLC, a subsidiary of Quad/Graphics, Inc. (NYSE: QUAD) ("Quad"), a leader in employer-powered...
News
Volpara Health Announces Jill Spear As New Executive Vice President Of Sales & Marketing
SEATTLE, June 23, 2021 /PRNewswire/ -- Volpara Health announced Jill Spear as the new Executive Vice President of Sales and Marketing who...
HealthTap Announces Sean Mehra as Chief Executive Officer
MOUNTAIN VIEW, Calif., June 23, 2021 /PRNewswire/ -- HealthTap, a leading virtual healthcare provider, today announced that the company's board of...
Immunicom Presentation Defines Breakthrough Subtractive Therapy’s Role in “New Era” Cancer Care at LSI’s Annual Emerging MedTech Summit
Immunicom CEO predicting cancer treatment standards will evolve with better quality-of-life and efficacy outcomes by employing novel non-pharmaceutical immune-oncology strategies...
xCures raises $12.69 million in Series A funding for their AI-powered precision oncology platform
OAKLAND, Calif., June 23, 2021 /PRNewswire/ -- xCures Inc., the leader in the patient-centric use of artificial intelligence (AI) and predictive modeling,...
Neutra Acquires Recreational Hemp Product Brand, Deity to Launch Delta-8 Product Line
KATY, TX / ACCESSWIRE / June 23, 2021 / Neutra Corp. (OTC PINK:NTRR) has announced it is acquired Deity Wellness,...
Healthcare Solutions Holdings Announces Recruitment Effort and Mission to Build National Healthcare System
GLEN COVE, NY / ACCESSWIRE / June 23, 2021 / Healthcare Solutions Holdings, Inc. (OTC PINK:VRTY) is pleased to announce...
Jaguar Health Set to Join Russell Microcap Index
Jaguar kicks off educational awareness contest about medicinal plantsSAN FRANCISCO, CA / ACCESSWIRE / June 23, 2021 / Jaguar Health,...
Novamind Welcomes Dr. Paul Thielking as Chief Scientific Officer
Led first-of-its-kind study of group psilocybin therapy for cancer patients with depressionCo-Investigator on a study to evaluate ketamine as a...
CureVac Provides Supervisory Board Update
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / June 23, 2021 / CureVac N.V. (NASDAQ:CVAC), a global clinical-stage biopharmaceutical company...
Chiesi accelerates path toward full sustainability despite COVID-19 pandemic
Ensuring continuing medical treatment for patients has been top priority during COVID-19 pandemic.Focus on Diversity & Inclusion in the workplace:...
Optimi Health Engages U.S. Based Law Firm for Patent Support
VANCOUVER, British Columbia, June 23, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or...
Medicenna Announces Submission of Clinical Trial Application in Australia for a Phase 1/2 Study of MDNA11
-- Initiation of the ABILITY Study, a first-in-human trial, is expected in the third quarter of 2021 -- Trial is...
RapidPulse Launches With $15 Million Series A Financing for Ischemic Stroke Therapy
Industry Veterans Join Team to Support the Development of Novel Cyclic Aspiration System for Ischemic StrokeMIAMI, June 23, 2021 (GLOBE...
Y-mAbs Provides Regulatory Update on Omburtamab for the Treatment of Patients with Neuroblastoma
NEW YORK, June 23, 2021 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical...
Icario and ConnectureDRX Partner to Deliver a Seamless Enrollment Experience for Medicare Advantage Members
Integration with Icario Connect enables agents to collect valuable insights during enrollment that improve satisfaction, member experience and early risk...
SpineCraft and Wishbone Medical Enter Distribution Agreement to Increase Access to Comprehensive Spine Deformity System for Pediatric Orthopedic Market
ASTRA Deformity Spine System The comprehensive product system addresses a broad range of complex spinal pathologies with a low-profile design...
Cybin to Present at the Life Sciences Investor Forum on June 24th
TORONTO, June 23, 2021 (GLOBE NEWSWIRE) -- Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) (“Cybin” or the “Company”), a biotechnology company focused on progressing...
Revolo Biotherapeutics Announces US FDA Approval of IND Application for Phase 2 Trial of ‘1104 in Eosinophilic Esophagitis
NEW ORLEANS and LONDON, June 23, 2021 (GLOBE NEWSWIRE) -- Revolo Biotherapeutics (“Revolo Bio” or the “Company”), a company developing...
SCYNEXIS to Present Commercial Launch Update for BREXAFEMME® (ibrexafungerp tablets)
BREXAFEMME® (ibrexafungerp tablets), for oral use A novel oral antifungal approved for the treatment of vulvovaginal candidiasis (VVC), also known...